Evidence map›Paper›PMID 39381227›Full record

ArticleHeliyon2024

Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts.

Nittaya Chamadol, Vallop Laopaiboon, Apiwat Jareanrat, Vasin Thanasukarn, Tharatip Srisuk, Vor Luvira, Poowanai Sarkhampee, Winai Ungpinitpong, Phummarat Khamvijite, Yutthapong Chumnanua and 11 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Nittaya ChamadolDepartments of Radiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Vallop LaopaiboonDepartments of Radiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Apiwat JareanratDepartments of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Vasin ThanasukarnDepartments of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Tharatip SrisukDepartments of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Vor LuviraDepartments of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Poowanai SarkhampeeDepartments of Surgery, Sunpasitthiprasong Hospital, Ubon Ratchathani Province, Thailand.
Winai UngpinitpongDepartments of Surgery, Surin Hospital, Surin Province, Thailand.
Phummarat KhamvijiteDepartments of Surgery, Surin Hospital, Surin Province, Thailand.
Yutthapong ChumnanuaDepartments of Surgery, Roi Et Hospital, Roi Et Province, Thailand.
Nipath NethuwakulDepartments of Surgery, Roi Et Hospital, Roi Et Province, Thailand.
Passakorn SodaratDepartments of Surgery, Roi Et Hospital, Roi Et Province, Thailand.
Samrit ThammaritDepartments of Surgery, Udonthani Hospital, Udon Thani Province, Thailand.
Anchalee TechasenDepartments of Clinical Microbiology, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Jaruwan ThuanmanData Management and Statistical Analysis Center (DAMASAC), Faculty of Public Health, Khon Kaen University, Khon Kean, Thailand.
Chaiwat TawarungruangData Management and Statistical Analysis Center (DAMASAC), Faculty of Public Health, Khon Kaen University, Khon Kean, Thailand.
Bandit ThinkhamropData Management and Statistical Analysis Center (DAMASAC), Faculty of Public Health, Khon Kaen University, Khon Kean, Thailand.
Prakasit Sa-NgiamwiboolDepartment of Pathology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Watcharin LoilomeSystems Biosciences and Computational Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.
Piya PrajumwongsCholangiocarcinoma Research Institute, Khon Kaen University, Khon Kaen, Thailand.
Attapol TitapunDepartments of Surgery, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Most cholangiocarcinoma (CCA) patients present with late stage of disease because of the difficulty to diagnosis at an early stage, resulting in poor survival of CCA patients. The Cholangiocarcinoma Screening and Care Program showed that ultrasound screening was an effective tool for detecting early stage CCA. This study aims to evaluate the survival outcome of patients diagnosed by ultrasound screening (US) compared to walk-in symptomatic patients. Methods: The retrospective clinical data and medical records for this study were accessed in June 30, 2021. 5-year survival rates (5-YSR) and median survival time (MST) of CCA were calculated using the Kaplan-Meier method. Multivariate analyses were performed for significant factors from univariate analyses. Results: A total of 711 histologically proven CCA cases were examined including ultrasound screening and walk-in groups. The screening group having 5-YSR was 53.9 %, and MST was of 67.2 months, while walk-in group, the 5-YSR was 21.9 % and MST was 15.6 months ( Conclusion: US is an effective tool for detecting early stage CCA leading to improve clinical outcome of CCA patients. Practically, US should be considered as a first tool for screening CCA in risk populations.

Indexed as

5-Year survival rateCASCAPCholangiocarcinomaEarly-stage screeningMedian survival timeMulticenter retrospective cohortsUltrasound screening

Identifiers

PMID39381227
PMCPMC11458967

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.